Search

Author/Creator Laarhoven, H.

1. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. (November 2018)

Authors:
Veenstra, V.; Damhofer, H.; Waasdorp, C.; Rijssen, L.; Vijver, M.; Dijk, F.; Wilmink, H.; Besselink, M.; Busch, O.; Chang, D.; Bailey, P.; Biankin, A.; Kocher, H.; Medema, J.; Li, J.; Jiang, R.; Pierce, D.; Laarhoven, H.; Bijlsma, M.
Journal:
Oncogenesis
Issue:
Volume 7(2018:Nov.)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PO-1583: Non-invasive radiomic imaging prediction of tumour hypoxia: biomarker for FLASH irradiation?. (November 2020)

Authors:
Sanduleanu, S.; Tamanupadhaya@gmail.com, T.; Klaassen, R.; Woodruff, H.; Hatt, M.; Kaanders, J.; Vrieze, O.; Laarhoven, H.; Subramiam, R.; Huang, S.H.; Bratman, S.; Dubois, L.; Miclea, R.; Di Perri, D.; Geets, X.; Crispin-Ortuzar, M.; Aptea, A.; Hun Oh, J.; Lee, N.; Humm, J.
Journal:
Radiotherapy and oncology
Issue:
Volume 152(2020)Supplement 1
Page Start:
S859
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search